武汉招聘

Major Accountabilities (Describe the main results of the role to be achieved )

ESTABLISH INTERNAL CONTROL

? Align local internal control procedures with global standards (NFCM/CLC/SP3) .
? Accurate assessment of internal controls based on NFCM/CLC/SP3 matrix.
? Establishing robust business internal controls, processes and SOPs as part of the Sandoz overall activities based on internal policies and guidelines / implementing procedures (NFCM/CLC/SP3/ SOX ) and on applicable local laws and regulations.

EMBED INTERNAL CONTROL

? Establish an annual local training plan for internal control (NFCM/CLC/SOX). Ensure evidenc-ing of training completion is completed.
? Conduct continuous training to ensure the full awareness of NFCM and NFCM related SOPs. (Especially new SOPs and new control updates).The training for NFCM Matrix to process own-ers should be conducted at least on a quarterly basis and Q&A testing and feedback form should be finished to reach process owner satisfactory.
? Monthly update for the internal control improvement suggestions to management (issues , actions, responsible personnel, remediation plan).
? Effective communications among different departments to provide solutions for the internal control issues according to NFCM requirements within 5 workings days.
? Ensure management of all the SOPs. (No overdue SOPs, SOPs align with NFCM/CLC/SP3 matrix requirements and current actual practices or policies.)
? Ensure audit readiness and quarterly follow-up with Internal Audit open issues and implement of agreed remediation actions.

ENFORCE INTERNAL CONTROL

? Conduct control testing according to NFCM/CLC/SP3 requirements to ensure all key control testing are completed and testing samples are archived within the testing framework timeline.
? Design control testing plan and testing procedures according to business requirements to ensure the testing procedure meets SOP’s requirements and all control points are designed into the testing procedures.

Key Performance Indicators / Measures of success
(Indicate how performance for this role will be measured)

Refer to Annual performance target setting.

? SOPs are in place for all relevant internal control areas according to NFCM/CLC/SP3 requirements. No overdue SOPs.
? SOPs are align with NFCM/CLC/SP3 requirements and actual practice & procedures.
? All NFCM/CLC controls reaches at least 3-Standardized and no internal control gaps exists.
? Region BPC review satisfactory results.
? Internal audit satisfactory results.
? No overdue audit points in issue track
? No miss of deadline for Global report(NFCM/CLC)

Job Dimensions (Indicate key facts and figures)


People responsibilities
Number of associates:
N/A
Financial responsibility:
(Budget, Cost, Sales, etc.)
Refer to Annual performance target setting.

Decision boundaries: N/A
Relationship in- and outside organisation:
Asia Pacific BPC Manager, All Sandoz Departments

Background (State the required education, experience level, and competency profile)

Education : University degree in finance/economics or equivalent
Languages: Fluent English both in Oral and written
Experience:
7+ years post qualifying experience.
Experience in Pharmaceutical industry internal auditing, Big 4 or similar is preferred.
Compliance experience in Pharmaceutical industry is a plus.
Be able to respond to changing priorities and deadlines.
Good team player and strong communication skills
Good excel and PowerPoint skills. SAP experience is a plus

Key Competencies:
？ Business Acumen
？ Drive for Results
？ Process Management
？ Integrity and Trust
？ Organizing

山德士是瑞士诺华集团的子公司，诺华集团是世界第三大制药公司、世界500强企业，是全球唯一在专利药、非专利药、疫苗和非处方药业务上都拥有领导地位的制药公司。诺华集团成立于1996年，由瑞士两家具有百年历史的世界著名制药公司汽巴-嘉基与山德士合并而成。山德士主要从事非专利药品的研发、生产和销售，业务涵盖原料药、制剂和生物制品，拥有950多个化合物和5000多种制剂，是全球第二大非专利药公司。山德士（中国）2007年1月正式开展中国业务，于当年12月20日向德国格兰泰公司收购了位于中山市火炬区健康基地的中山格兰泰制药，并在中山成立了山德士(中国)制药有限公司，注册资金2200万美元，投资总额达3500万美元.